Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

This rule by the U.S. Drug Enforcement Administration and Department of Health and Human Services extends flexibility for medications prescribed via telemedicine. The rule began during the COVID-19 pandemic and extends until December 31st, 2025.